Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4 small nuclear 84, pseudogene (RNU4-84P) is annotated as a pseudogene that shares sequence similarity with the functional U4 spliceosomal RNA genes, such as *RNU4-2*.[2] Pseudogenes do not code for functional proteins or RNA molecules, and there is no evidence that RNU4-84P produces a functional transcript or has a role in splicing, neurodevelopment, or disease.[2] It should not be confused with *RNU4-2*, whose variants are implicated in neurodevelopmental disorder syndromes and whose functional RNA is a critical part of the spliceosome in mRNA processing.[1][3][4][5] There is no evidence or reports of drugs or biomarker usage, molecular functions, or disease roles for RNU4-84P. Its annotation as a pseudogene indicates it does not function as a therapeutic target or as a molecular target in disease contexts. The primary reason this entry is "incorrect" is that it is not a bona fide target, but rather a non-functional pseudogene.[2] Ambiguity arises because *RNU4-84P* is a pseudogene, while function and disease relevance are established only for the functional gene *RNU4-2*.[1][3][4][5] If the intent was to ask about the U4 small nuclear RNA gene with known biological and disease relevance, *RNU4-2* should be used; this gene is relevant in neurodevelopmental diseases and encodes a non-coding RNA critical for the spliceosome.[1][3][4][5] No information supports any therapeutic or biological target status for RNU4-84P, and there is risk of confusion due to similar nomenclature.[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 84, pseudogene (RNU4-84P).